Your Location:
Home >
Browse articles >
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 11, Pages: 118-124(2025)
DOI: 10.13422/j.cnki.syfjx.20250319
Accepted:05 March 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 2 ) Tabs( 8 )
References
Publication Info
Metrics
397
Views
586
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Regulatory Pathways of Cell Apoptosis in Diabetic Kidney Disease and Intervention by Traditional Chinese Medicine: A Review
Related Author
DONG Yuanguang
YUAN Mingdian
SUN Yingying
YANG Ying
ZHAO Jiao
SUN Xiaofei
WANG Jiaxin
CUI Peng
Related Institution
Liaoning University of Traditional Chinese Medicine
Liaoning Cancer Hospital
Affiliated Hospital of Liaoning University of TCM
General Hospital of Ningxia Medical University
School of Clinical Chinese Medicine, Gansu University of Chinese Medicine


